#VisualAbstract: A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus
1. In this double-blind phase 3 trial involving patients undergoing hemodialysis who had moderate-to-severe pruritus, a clinically significant decrease in ...
1. In this double-blind phase 3 trial involving patients undergoing hemodialysis who had moderate-to-severe pruritus, a clinically significant decrease in ...
1. In this double-blind phase 3 trial involving patients undergoing hemodialysis who had moderate-to-severe pruritus, a clinically significant decrease in ...
1. In this retrospective quality improvement cohort study from the United States, a multidisciplinary approach was linked with increased rates ...
For patients with end-stage renal disease, the type of hemodialysis access selected has a direct effect on complication rates and ...
1. In this observational cohort study of patients with end-stage renal disease (ESRD) undergoing hemodialysis, there was no observed difference ...
1. In this randomized clinical trial, patients on hemodialysis who received a vitamin D receptor activator (VDRA) did not have ...
1. Physicians working in settings that provide emergency only hemodialysis (EOHD) reported higher rates of professional burnout. 2. Physicians providing ...
1. In this cross-sectional study, of those patients on maintenance hemodialysis that were referred to hospice care, 41.5% received care ...
1. In this multi-center, international, randomized, controlled trial, use of fish oil supplementatio at the time of arteriovenous fistula (AVF) ...
1. Hemodialysis patients who received peginesatide had similar hemoglobin levels and similar rates of adverse events as patients who received ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.